ProMetic Life Sciences (TSE:PLI) Stock Crosses Above 50-Day Moving Average of $0.00

Shares of ProMetic Life Sciences Inc. (TSE:PLIGet Rating) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.00 and traded as high as C$13.72. ProMetic Life Sciences shares last traded at C$13.60, with a volume of 921 shares traded.

ProMetic Life Sciences Price Performance

The company has a current ratio of 4.06, a quick ratio of 3.66 and a debt-to-equity ratio of 37.47. The stock has a market cap of C$317.06 million and a price-to-earnings ratio of -0.22.

ProMetic Life Sciences Company Profile

(Get Rating)

Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.

See Also

Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.